CYB5A and prostate carcinoma: In various cancer types, such as prostate cancer and adrenal cortical cancer, scholars found that CYB5A is significantly downregulated in cancer compared with the corresponding adjacent normal tissues through statistical analysis without subjective impression [4–6].